FIELD: chemistry.
SUBSTANCE: invention relates to a heterocyclic imidazole compound of general formula (I), in which R is hydrogen, halogen, C1-C6alkoxy or C1-C6halogenalkyl; one of X, Y and Z is nitrogen, and others are CH or one of X, Y and Z is CH, and others are nitrogen; M is nitrogen or CR1; R1 is hydrogen, oxygen, C1-C6alkyl or C1-C6halogenalkyl. Invention also relates to a method for producing a compound of general formula (I), to use of the compound.
I.
EFFECT: new heterocyclic imidazole compounds of general formula (I) are produced, having inhibiting properties of poly(ADP-ribose)-polymerase (PARP).
14 cl, 5 tbl, 24 ex
Title | Year | Author | Number |
---|---|---|---|
DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE | 2009 |
|
RU2514937C2 |
IMIDAZOPYRIDIN-2-ONE DERIVATIVES, HAVING mTOR INHIBITING ACTIVITY | 2009 |
|
RU2478636C2 |
HETEROARYL COMPOUNDS, COMPOSITIONS CONTAINING THEM AND METHODS OF TREATING WITH USE OF SUCH COMPOUNDS | 2007 |
|
RU2478635C2 |
BICYCLIC NITROIMIDAZOLES COVALENTLY CONNECTED TO REPLACED PHENYLOXAZOLYDINONES | 2009 |
|
RU2504547C2 |
USING EP4 RECEPTOR LIGANDS IN TREATMENT OF IL-6-MEDIATED DISEASES | 2003 |
|
RU2285527C2 |
HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS | 2018 |
|
RU2797822C2 |
BICYCLIC COMPOUND AND USE THEREOF FOR SUV39H2 INHIBITION | 2016 |
|
RU2729187C1 |
PROTEIN KINASE INHIBITORS FOR ENHANCING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH | 2019 |
|
RU2822216C2 |
SUBSTITUTED IMIDAZOQUINOLINES | 2018 |
|
RU2768629C2 |
AZABENZIMIDAZOLE COMPOUNDS AND A PHARMACEUTICAL COMPOSITION | 2019 |
|
RU2804485C2 |
Authors
Dates
2019-04-25—Published
2016-04-15—Filed